Corporate Governance4 Nov 2026, 02:52 pm
Ennature Bio Pharma Trading Window Closure
AI Summary
Ennature Bio Pharma Ltd has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from Wednesday, November 4th, 2026, and will remain in effect for 48 hours after the declaration of the financial results for the quarter and half-year ending September 30th, 2026. This measure is in accordance with the company's Code of Conduct for Regulating, Monitoring and Reporting Trading in Securities.
Key Highlights
- Trading window closed from November 4th, 2026.
- Closure is until 48 hours post financial results declaration.
- Results pertain to Q2 FY27 and H1 FY27.
- Adheres to company's insider trading code of conduct.
Price Impact
More from ENNATURE